Images List Premium Download Classic

Dermatitis

Dermatitis-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Composition comprising gpcr19 agonist as an active ingredient for preventing or treating allergic dermatitis
Shaperon Inc.
July 13, 2017 - N°20170196895

The present invention is about a pharmaceutical composition, an oral preparation, and an injection preparation containing a g protein-coupled receptor19 (gpcr19) agonist, specifically sodium taurodeoxycholate(hy2191) and its derivative, as an active ingredient for preventing or treating allergic skin diseases. The present invention is also about an external preparation and a cosmetic composition containing said pharmaceutical composition for preventing and ...
Ibs related testing and treatment
Shaperon Inc.
July 13, 2017 - N°20170196498

Methods and items useful at least therein are provided for ibs related testing and treatment. Disclosed is a patch useful in determining if one or more test materials can cause allergic contact dermatitis in a patient. A kit containing information on use and that may include such a patch and/or test material(s) is also disclosed. A method of ...
Methods of treating atopic dermatitis with il-31 monoclonal antibodies
Zymogenetics, Inc.
June 29, 2017 - N°20170182160

Novel compositions derived from antigen-binding sites of immunoglobulins having affinity for il-31 are provided. The compositions exhibit immunological binding properties of antibody molecules capable of binding specifically to a human il-31. Cdr regions derived from same or different immunoglobulin moieties are provided. Also provided are single chain polypeptides wherein vh and vl domains are attached. The sfv molecules can include ...
Dermatitis Patent Pack
Download + patent application PDFs
Dermatitis Patent Applications
Download + Dermatitis-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dermatitis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Binding inhibitor between tctp dimer type ige-dependent histamine releasing factor and receptor thereof, and use ...
Ewha University - Industry Collaboration Foundation
June 08, 2017 - N°20170158761

The present invention relates to a receptor-binding domain of an ige-dependent histamine releasing factor (hrf), and a use thereof, and more specifically, ascertains, as an hrf structual region, and a fl domain and an h2 domain which bind to a receptor of hrf existing in a cell membrane, ascertains the c-terminus domain of the hrf, and ascertains that a material ...
Human fgfr2b extracellular domain and nucleic acid for coding same
Guangzhou Shenglu Biotech Limited Company
June 01, 2017 - N°20170152299

Provided are wild-type, s252w mutant-type, and p253r mutant-type fgfr2b extracellular segments and truncated proteins thereof, coding genes of the foregoing proteins, a recombinant vector comprising the genes, a host cell, a method for preparing the proteins, and a fusion protein of the proteins and an fc segment. Also provided are applications of the proteins and a composition ...
2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinase(syk) inhibitors
Guangzhou Shenglu Biotech Limited Company
May 25, 2017 - N°20170145019

The present invention relates to compounds of formula (ia), (ib) or (ic): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly asthma, copd, allergic rhinitis, chronic sinusitis, atopic dermatitis, ...
Dermatitis Patent Pack
Download + patent application PDFs
Dermatitis Patent Applications
Download + Dermatitis-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dermatitis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
Zymogenetics, Inc.
May 18, 2017 - N°20170136045

The present discovery pertains generally to the field of therapeutic compounds. More specifically the present discovery pertains to certain di-isopropyl-phosphinoyl-alkanes as described herein, dipa-1-5, dipa-1-6, dipa-1-7, dipa-1-8, and dipa-1-9, collectively referred to herein as “dipa compounds”, that are useful, for example, in the treatment of disorders (e. G., diseases) including: sensory ...
Acetylcholinesterase inhibitors for treatment of dermatological conditions
Attillaps Holdings
May 18, 2017 - N°20170135978

Embodiments of the invention involve treating skin afflictions by the topical or oral use of acetylcholinesterase inhibitor. By effectively reducing or eliminating the population of demodex mites in affected skin areas and areas where demodex mites may exist, this treatment achieves a more complete remission of clinical signs and symptoms of the skin afflictions than any previously described method. Embodiments ...
Method of reducing pruritus using il-31 monoclonal antibodies
Zymogenetics, Inc.
May 11, 2017 - N°20170129952

The present invention relates to methods of treating pruritic diseases, including but not limited to contact dermatitis, atopic dermatitis, drug induced delayed type cutaneous allergic reactions, toxic epidermal necrolysis, cutaneous t cell lymphoma, bullous pemphigoid, alopecia wereata, vitiligo, acne rosacea, prurigo nodularis, scleroderma, herpes simplex virus, or combination thereof by administering il-31 monoclonal antibodies. The invention provides the hybridomas that ...
Humanized anti-ige antibodies that crosslink cd23 on b lymphocytes but do not sensitize mast cells
Academia Sinica
May 04, 2017 - N°20170121425

A novel humanized anti-ige antibody is disclosed. The antibody is capable of binding to free ige, membrane-bound ige on b lymphocytes, ige bound by cd23, but not to ige bound by high-affinity ige. Fc receptor on mast cells. The present invention relates to the treatment of ige-mediated diseases, including allergic asthma, allergic rhinitis, atopic dermatitis, food allergy, chronic spontaneous (idiopathic) ...
Enzyme treatment of foodstuffs for celiac sprue
The Board Of Trustees Of The Leland Stanford Junior University
May 04, 2017 - N°20170119860

Administering an effective dose of glutenase to a celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
Methods and compositions for dermatological use comprising clobetasol and halobetasol and biopolymers
Apex Laboratories Private Limited
May 04, 2017 - N°20170119792

Disclosed are compositions comprising topical corticosteroids, such as clobetasol propionate and halobetasol propionate, and a biopolymer in a cream base, wherein the cream base comprises a primary and a secondary emulsifier, a waxy material, a co-solvent, a preservative, an acid, a chelating agent, a buffering agent, and water. The biopolymer comprises chitosan. The compositions disclosed herein are suitable for the ...
Methods and compositions for dermatological use comprsing betamethasone and biopolymers
Apex Laboratories Private Limited
May 04, 2017 - N°20170119791

Disclosed are compositions comprising betamethasone, such as betamethasone dipropionate or betamethasone valerate, and a biopolymer in a cream base, wherein the cream base comprises a primary and a secondary emulsifier, a waxy material, a co-solvent, a preservative, an acid, a chelating agent, a buffering agent, and water. The biopolymer comprises chitosan. The compositions disclosed herein are suitable for the treatment ...
Dermatitis Patent Pack
Download + patent application PDFs
Dermatitis Patent Applications
Download + Dermatitis-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dermatitis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for treatment of inflammatory skin conditions using allantoin
Scioderm, Inc.
April 20, 2017 - N°20170105968

Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0. 5% to about 15. 0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis ...
Compositions and methods of treatment of inflammatory skin conditions using allantoin
Scioderm, Inc.
April 20, 2017 - N°20170105967

Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0. 5% to about 15. 0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis ...
Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
National Jewish Medical Research Center
April 06, 2017 - N°20170096484

The present invention relates to methods of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive t cell. In particular, diseases or disorders including contact dermatitis, drug induced delayed type cutaneous allergic reactions, toxic epidermal necrolysis, cutaneous t cell lymphoma, bullous pemphigoid, alopecia aereata, vitiligo, acne rosacea, prurigo nodularis, and herpes simplex virus, or combination thereof ...
Composition for improving skin conditions comprising a fragment of human heat shock protein 90a as ...
Regeron, Inc.
March 30, 2017 - N°20170087211

Liposomal and/or nano-liposomal encapsulated hsp90a, hpf polypeptide (115 aa) and novel polypeptides hpf Δc1 (101 aa) and hpfΔc2 (87 aa), as well as methods for manufacturing/preparing and using the compositions, are disclosed. Chimeric fusion proteins that include an hsp90a, hpf-polypeptide, hpf Δc1 or hpfΔc2 polypeptide are presented. Transformed cell lines and expression vectors ...
Temperature controlled hypoallergenic garments or pads
Regeron, Inc.
March 30, 2017 - N°20170087010

A hypoallergenic garment is provided that offers relief by achieving a desirable cooling or heating effect in an individual experiencing pain or discomfort. It can be used for treatment of conditions such as itching, burning, yeast or bacterial infection, urethral pain, inflammation, urinary tract infections, dermatitis, vaginal varicosity, menopausal perspiration, post-surgery swelling, edema due to a sports injury, swelling due ...
Antibodies that specifically bind to tl1a
Cephalon, Inc.
March 23, 2017 - N°20170081400

Recombinantly expressed variant antibodies that have enhanced affinity for tl1a and enhanced potency relative to the parent antibody from which they were derived are provided. The antibodies inhibit the interaction between tl1a and the death receptor 3 (dr3). The antibodies, or a composition thereof, may be used to treat one or more of asthma, copd, pulmonary fibrosis, cystic fibrosis, ...
Methods and systems for treatment of inflammatory diseases with nitric oxide
Transdermal Biotechnology, Inc.
March 23, 2017 - N°20170080021

The present invention generally relates to compositions and methods for treatment of various inflammatory diseases, such as inflammatory dermatoses and other conditions, e. G., using nitric oxide. Examples of such dermatoses include psoriasis, atopic dermatitis, and contact dermatitis. The nitric oxide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is ...
Methods and compositions for dermatological use comprsing hydrocortisone acetate and biopolymers
Apex Laboratories Private Limited
March 23, 2017 - N°20170080013

Disclosed are compositions comprising hydrocortisone acetate and a biopolymer, chitosan, in a cream base, wherein the cream base comprises a primary and a secondary emulsifier, a waxy material, a co-solvent, a preservative, an acid, a chelating agent, a buffering agent, and water. The compositions disclosed herein are suitable for the treatment of dermatological conditions including but not limited to healing ...
Loading